ABCG2, CD44 and SOX9 are increased with the acquisition of drug resistance and involved in cancer stem cell activities in head and neck squamous cell carcinoma cellsK. Murakami, Emika Ohkoshi|Experimental and Therapeutic Medicine|2022Cited by 24
Induction of immunogenic necroptosis by shikonin in drug‑resistant head and neck squamous cell carcinoma cellsSatsuki Kishita, Emika Ohkoshi|Oncology Reports|2025Cited by 0